Transdermal fentanyl to parenteral morphine route switch and drug rotation in refractory cancer cachexia

Citation:
Alsirafy SA, Alabdullateef SH, Elyamany AM, Hassan AD, Almashiakhi M. "Transdermal fentanyl to parenteral morphine route switch and drug rotation in refractory cancer cachexia." BMJ Supportive & Palliative Care. 2022;12:e184-e186. copy at www.tinyurl.com/26224r5g

Abstract:

It is recommended not to use transdermal fentanyl (Fe) patches (TFP) in cancer cachexia but TFP may be the only available option for pain. Limited evidence suggests lower Fe absorption from TFP in cachexia. We describe a case of metastatic breast cancer with refractory cachexia. Her pain was uncontrolled on TFP and was route switched and drug rotated to intravenous morphine (M). We were conservative and did not use the 1:100 TFP to oral M conversion ratio. Assuming opioid needs were similar before and after switch/rotation, the suitable conversion ratio in this case was about 1:25. Absent clear guidelines on converting from TFP in cachexia, it is better to avoid TFP. When essential to use TFP in cachexia, caution should be taken when switching from TFP to avoid overdose.

Notes:

n/a

Related External Link

Tourism